Bionano Genomics, Inc. (BMV:BNGO)

Market Cap	350.08M
Revenue (ttm)	517.20M
Net Income (ttm)	-1.40B
Shares Out	n/a
EPS (ttm)	-608.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,020
Average Volume	2,008
Open	37.20
Previous Close	37.00
Day's Range	37.20 - 39.00
52-Week Range	30.80 - 510.00
Beta	n/a
RSI	35.80
Earnings Date	Nov 14, 2025

About Bionano Genomics

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome anal...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 100
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: BNGO

Financial Performance

In 2024, Bionano Genomics's revenue was $30.78 million, a decrease of -14.79% compared to the previous year's $36.12 million. Losses were -$112.02 million, -51.82% less than in 2023.

Financial numbers in USD